The Poisons and Therapeutic Goods Act 1966 (NSW) and the Poisons and Therapeutic Goods Regulation 2008 (NSW) form the primary legislative framework that regulates the supply of medicines, poisons, and therapeutic goods in New South Wales.
This framework is scheduled to be replaced on 5 November 2026 by the Medicines, Poisons and Therapeutic Goods Act 2022 (NSW) (the Act), which was passed in NSW Parliament in November 2022, along with the Medicines, Poisons and Therapeutic Goods Regulation 2026 (NSW) (the Regulation), which was approved by the Minister on 3 July 2026.
View the key changes under the new laws here
The Medicines, Poisons and Therapeutic Goods Regulation 2026 has now been published, and the Medicines, Poisons and Therapeutic Goods Act 2022 and Regulation will commence on 5 November 2026.
You can find the legislation at the following links:
To see what this means for you, visit the Medicines, Poisons and Therapeutic Goods legislation webpage.
Information and guidance will be circulated to health practitioners and industry. We encourage everyone to review this information once available to prepare for the upcoming changes.
Subscribe to stay up to date with these important changes.
Subscribe to Pharmaceutical Services news and updates
NSW Health will support health practitioners and industry throughout this transition.
Read the announcement of the new laws.
NSW Health is seeking expressions of interest (EOI) for membership of the new statutory committees that are to be established under the Medicines, Poisons, and Therapeutic Goods Act 2022. These committees include the Regulatory Advisory Committee and Clinical Advisory Committee, and these will be established on commencement of the Act.
For more information see Advisory committee membership – Medicines, Poisons and Therapeutic Goods Act 2022.
The consultation on proposed regulatory changes aimed at strengthening controls on cosmetic-use substances closed on 27 February 2026.
NSW Health would like to thank everyone who provided submissions and feedback.